BellBrook Labs Partners with Lucerna-Chem for Distribution of Transcreener HTS Assays in Switzerland
Madison, WI (PRWEB) March 06, 2014 -- BellBrook Labs has partnered with Lucerna-Chem for distribution of their Transcreener® HTS Assay products in Switzerland as of January 2014. The partnership leverages Lucerna-Chem’s existing supply arrangements with pharma and biotech companies in Basel and key academic centers focused on drug discovery. Lucerna-Chem will distribute BellBrook’s full product line of Transcreener HTS assays covering thousands of enzyme drug targets, including kinase assays, methyltransferase assays, GTPase assays, phosphodiesterase assays and glycosyltransferase assays.
Transcreener assays are the only method for direct detection of nucleotide enzyme products, which provides significant advantages over other HTS enzyme assay methods in terms of sensitivity, signal stability and resistance to interference. They are designed for an automated HTS environment with single addition, mix-and-read format and overnight reagent and signal stability and are available in three different fluorescent readouts; FI, FP and TR-FRET.
Lucerna-Chem will also distribute BellBrook’s new Transzyme™ product line of turn-key methyltransferase assay kits that combine pre-calibrated purified methyltransferase enzymes and substrates from Reaction Biology with BellBrook’s Transcreener EPIGEN Methyltransferase detection reagents. The Transzyme kits allow investigators to start screening or profiling methyltransferases without the costly reagent testing and assay development normally associated with these complex enzyme systems.
About BellBrook Labs. BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions for enzymes and phenotypic assays. The company’s Transcreener® HTS enzyme assays, used by all of the major pharmaceutical companies, make it easy to screen thousands of different enzymes, including validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. The iuvo™ Microconduit Array technology and assay screening service is a line of unique microscale devices for miniaturization and automation of advanced cell models that are more representative of human physiology.
About Lucerna-Chem. Lucerna-Chem AG, Switzerland, is a privately held company that was founded in 1978. The company has become one of the leading distributors for life science products in Switzerland, offering state of the art research tools for immunology, signaling, molecular, cell and stem cell biology. Working closely with a number of innovative manufacturers, Lucerna-Chem offers a wide range of products at competitive prices. The company is dedicated to provide high quality sales, support and supply service for academic and industrial customers in Switzerland. The experienced and motivated team stands for efficiency, reliability and professional service.
Bob Lowery, BellBrook Labs, http://www.bellbrooklabs.com, +1 (608) 227-4501, [email protected]
Share this article